Wird geladen...
Evaluation of thyroid nodules classified as Bethesda category III on FNAC
BACKGROUND: The Bethesda (BSRTC) category III has been ascribed a malignancy rate of 5–15%, however, the probability of malignancy remains variable. AIM: To evaluate category III with respect to its rate and risk of malignancy and substratify it. SETTINGS AND DESIGN: Atypia of undetermined significa...
Gespeichert in:
| Veröffentlicht in: | J Cytol |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5259932/ https://ncbi.nlm.nih.gov/pubmed/28182068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-9371.197590 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|